I'rom Group Co

I'rom Group Co FCF Conversion

Delisted

The FCF Conversion Rate (FCF/EBITDA) of I'rom Group Co (2372.T) as of Oct 16, 2026 is -252.79 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was -23.80 % — a change of 962.14% (lower).

FCF Conversion

-252.79 %

YoY

962.14%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of I'rom Group Co is 2024 -252.79 % . FCF Conversion Rate (FCF/EBITDA) of I'rom Group Co was 2023 -23.80 % . It decreases by 962.14% lower compared to the previous year.

The I'rom Group Co FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2017
-715.69 JPY
Jan 1, 2018
114.76 JPY
Jan 1, 2019
-149.56 JPY
Jan 1, 2020
-61.73 JPY
Jan 1, 2021
-164.68 JPY
Jan 1, 2022
29.98 JPY
Jan 1, 2023
-23.80 JPY
Jan 1, 2024
-252.79 JPY
The I'rom Group Co FCF Conversion history
YEARFCF ConversionYoY
-252.79 %+962.14%
-23.80 %-179.37%
29.98 %-118.21%
-164.68 %+166.76%
-61.73 %-58.73%
-149.56 %-230.32%
114.76 %-116.04%
-715.69 %-1,730.49%
43.89 %-66.54%
131.19 %+757.10%
15.31 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

I'rom Group Co Stock analysis

What does I'rom Group Co do? I'rom Group Co. Ltd is a Japanese company specialized in medical services. It was founded in April 2007 and is headquartered in Tokyo, Japan. The company has become a significant player in the medical service sector in Japan within a few years. Its business model focuses on medical services and the sale of medical products, specifically in the areas of Life-Science and Clinical Research. I'rom offers support in clinical studies, distributes medications and medical devices, and provides CRM services. The company is divided into different divisions that offer various specialized products and services such as clinical research services, medical development services, corporate staffing services, and CRM services. I'rom also offers a wide range of medical products, mainly targeting the Japanese market. In conclusion, I'rom Group Co. Ltd is a leading company in the field of medical services in Japan, providing integrated support in product development and marketing for the life science and healthcare industries. I'rom Group Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about I'rom Group Co stock

FCF Conversion Rate (FCF/EBITDA) of I'rom Group Co is -252.79 % in 2024.

FCF Conversion Rate (FCF/EBITDA) of I'rom Group Co changed from -23.80 % to -252.79 %, representing a 962.14% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) I'rom Group Co since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s I'rom Group Co with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — I'rom Group Co

All Key Metrics — I'rom Group Co